Discipline Over Vibes
The goal is to reduce ad hoc judgment by standardizing how Phase 2 evidence is turned into a forecast, shortlist, and communication flow.
About Us
Our Mission
BioLensTracker is building a disciplined way to identify which drug programs appear more likely to succeed in Phase 3 using evidence found in Phase 2 trial abstracts.
The project sits at the intersection of clinical-text extraction, calibrated forecasting, and operational monitoring. We turn a large catalyst universe into a smaller, evidence-backed set of picks, monitor those names through the active round, and communicate results to subscribers as events resolve.
Auditability Matters
Structured variables, preserved evidence quotes, calibration checks, and explicit artifacts all support reviewability rather than black-box output.
Operations Matter Too
The product is not just a score. It includes sourcing, filtering, monitoring, confirmation, and subscriber-ready updates tied to actual event windows.